Dipal Doshi
CEO, Director at Entrada Therapeutics, Inc. (TRDA)
Dipal Doshi has filed 48 insider reports with the SEC since November 2021, as CEO and director at Entrada Therapeutics, Inc. (TRDA) and director at Azenta, Inc. (AZTA). Dipal Doshi made no open-market purchases or sales in the last 12 months. The latest filing, on September 3, 2026, reports shares withheld for taxes or exercise price at Entrada Therapeutics, Inc. (TRDA).
- Filings
- 48
- Companies
- 2
- Bought on market
- None
- Sold on market
- $1.39M
Companies where Dipal Doshi is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| CEO, Director | 517,290 | $1.39M | $4.35 | Sep 3, 2026 | |||
| Directorsince January 2025 | 9,703 | $44.80 | Feb 6, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Sep 2, 2026TRDACEO Doshi Dipal covered exercise/tax liability with 8,724 shares, decreasing direct ownership by 2% to 517,290 units to satisfy withholding taxForm 4Shares withheld for taxes or exercise price
- Mar 3, 2026TRDACEO Doshi Dipal was granted 139,400 shares and covered exercise/tax liability with 29,050 shares, increasing direct ownership by 27% to 526,014 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Feb 5, 2026AZTADirector Doshi Dipal was granted 5,663 units of Common, increasing direct ownership by 140% to 9,703 unitsForm 4Grant or award
- Sep 2, 2025TRDACEO Doshi Dipal covered exercise/tax liability with 8,723 shares, decreasing direct ownership by 2% to 415,664 unitsForm 4Shares withheld for taxes or exercise price
- Mar 3, 2025TRDACEO Doshi Dipal was granted 116,200 shares and covered exercise/tax liability with 17,566 shares, increasing direct ownership by 30% to 424,387 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Feb 7, 2025AZTADirector Doshi Dipal was granted 4,040 units of CommonForm 4Grant or award
- Jan 31, 2025AZTADipal Doshi became an insiderForm 3New insider
- Sep 5, 2024TRDACEO Doshi Dipal covered exercise/tax liability with 8,722 shares, decreasing direct ownership by 3% to 325,753 unitsForm 4Shares withheld for taxes or exercise price
- Jul 15, 2024-$33.9KTRDACEO Doshi Dipal sold $33,897 worth of shares (1,900 units at $17.84), decreasing direct ownership by 0.56% to 334,475 unitsForm 4Open-market sale10b5-1 plan
- Jul 15, 2024~$244KTRDADipal Doshi plans to sell 14,238 shares (~$244K)Form 144Planned sale10b5-1 plan
- Jun 13, 2024-$16.2KTRDACEO Doshi Dipal sold $16,174 worth of shares (1,000 units at $16.17), decreasing direct ownership by 0.30% to 336,375 unitsForm 4Open-market sale10b5-1 plan
- Jun 13, 2024~$31.8KTRDADipal Doshi plans to sell 2,000 shares (~$31.8K)Form 144Planned sale10b5-1 plan
- May 17, 2024-$45.1KTRDADoshi Dipal sold $45,129 worth of shares (3,000 units at $15.04), decreasing direct ownership by 0.88% to 337,375 unitsForm 4Open-market sale10b5-1 plan
- May 16, 2024~$43.5KTRDADipal Doshi plans to sell 3,000 shares (~$43.5K)Form 144Planned sale10b5-1 plan
- Mar 5, 2024TRDADoshi Dipal was granted 104,700 shares and covered exercise/tax liability with 7,604 shares, increasing direct ownership by 40% to 340,375 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Feb 15, 2024-$15KTRDADoshi Dipal sold $15,000 worth of shares (1,000 units at $15.00), decreasing direct ownership by 0.41% to 243,279 unitsForm 4Open-market sale10b5-1 plan
- Feb 15, 2024~$44.3KTRDADipal Doshi plans to sell 3,000 shares (~$44.3K)Form 144Planned sale10b5-1 plan
- Jan 16, 2024-$16KTRDADoshi Dipal sold $15,990 worth of shares (1,000 units at $15.99), decreasing direct ownership by 0.41% to 244,279 unitsForm 4Open-market sale10b5-1 plan
- Dec 20, 2023-$15KTRDADoshi Dipal sold $15,000 worth of shares (1,000 units at $15.00), decreasing direct ownership by 0.41% to 245,279 unitsForm 4Open-market sale10b5-1 plan
- Nov 13, 2023-$16.2KTRDADoshi Dipal sold $16,230 worth of shares (1,000 units at $16.23), decreasing direct ownership by 0.40% to 246,279 unitsForm 4Open-market sale10b5-1 plan
- Nov 13, 2023~$49.9KTRDADipal Doshi plans to sell 3,000 shares (~$49.9K)Form 144Planned sale10b5-1 plan
- Oct 17, 2023-$15KTRDADoshi Dipal sold $15,000 worth of shares (1,000 units at $15.00), decreasing direct ownership by 0.40% to 247,279 unitsForm 4Open-market sale10b5-1 plan
- Sep 13, 2023-$15KTRDASEC Form 4: Doshi Dipal sold $15,000 worth of shares (1,000 units at $15.00), decreasing direct ownership by 0.40% to 248,279 unitsForm 4Open-market sale10b5-1 plan
- Sep 5, 2023TRDASEC Form 4: Doshi Dipal was granted 49,650 shares and covered exercise/tax liability with 1,440 shares, increasing direct ownership by 24% to 249,279 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Aug 14, 2023-$15.7KTRDASEC Form 4: Doshi Dipal sold $15,671 worth of shares (1,000 units at $15.67), decreasing direct ownership by 0.49% to 201,069 unitsForm 4Open-market sale10b5-1 plan
- Apr 27, 2023-$27.4KTRDASEC Form 4 filed by Doshi DipalForm 4Open-market sale10b5-1 plan
- Apr 17, 2023-$37.7KTRDASEC Form 4 filed by Doshi DipalForm 4Open-market sale10b5-1 plan
- Mar 1, 2023TRDASEC Form 4 filed by Doshi Dipal (Amendment)Form 4Grant or award
- Mar 27, 2023-$29.4KTRDASEC Form 4 filed by Doshi DipalForm 4Open-market sale10b5-1 plan
- Feb 28, 2023-$24KTRDASEC Form 4: Doshi Dipal sold $24,000 worth of shares (2,000 units at $12.00) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 161,835 unitsForm 4Open-market sale10b5-1 plan
- Jan 27, 2023-$24KTRDASEC Form 4: Doshi Dipal sold $24,001 worth of shares (2,000 units at $12.00) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 163,835 unitsForm 4Open-market sale10b5-1 plan
- Jan 9, 2023-$36.2KTRDASEC Form 4: Doshi Dipal sold $36,196 worth of shares (2,410 units at $15.02) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 165,835 unitsForm 4Open-market sale10b5-1 plan
- Dec 29, 2022-$219KTRDASEC Form 4: Doshi Dipal sold $219,119 worth of shares (14,590 units at $15.02) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 168,245 unitsForm 4Open-market sale10b5-1 plan
- Nov 28, 2022-$27.8KTRDASEC Form 4: Doshi Dipal sold $27,826 worth of shares (2,000 units at $13.91) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 182,835 unitsForm 4Open-market sale10b5-1 plan
- Oct 27, 2022-$293KTRDASEC Form 4: Doshi Dipal sold $292,512 worth of shares (14,061 units at $20.80) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 184,835 unitsForm 4Open-market sale10b5-1 plan
- Oct 24, 2022-$111KTRDASEC Form 4: Doshi Dipal sold $110,713 worth of shares (5,939 units at $18.64) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 198,896 unitsForm 4Open-market sale10b5-1 plan
- Sep 28, 2022-$161KTRDASEC Form 4: Doshi Dipal sold $161,442 worth of shares (10,587 units at $15.25) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 204,835 unitsForm 4Open-market sale10b5-1 plan
- Sep 23, 2022-$66.8KTRDASEC Form 4: Doshi Dipal sold $66,838 worth of shares (4,425 units at $15.10) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 215,422 unitsForm 4Open-market sale10b5-1 plan
- Sep 15, 2022-$3,008TRDASEC Form 4: Doshi Dipal sold $3,008 worth of shares (200 units at $15.04) as part of a pre-agreed trading plan, decreasing direct ownership by 0.09% to 219,847 unitsForm 4Open-market sale10b5-1 plan
- Sep 9, 2022-$27KTRDASEC Form 4: Doshi Dipal sold $27,039 worth of shares (1,788 units at $15.12) as part of a pre-agreed trading plan, decreasing direct ownership by 0.81% to 220,047 unitsForm 4Open-market sale10b5-1 plan
- Sep 1, 2022TRDASEC Form 4: Doshi Dipal was granted 15,125 shares, increasing direct ownership by 7% to 221,835 unitsForm 4Grant or award
- Aug 31, 2022-$25.4KTRDASEC Form 4: Doshi Dipal sold $25,435 worth of shares (2,000 units at $12.72) as part of a pre-agreed trading plan, decreasing direct ownership by 0.96% to 206,710 unitsForm 4Open-market sale10b5-1 plan
- Jul 27, 2022-$24KTRDASEC Form 4: Doshi Dipal sold $24,000 worth of shares (2,000 units at $12.00) as part of a pre-agreed trading plan, decreasing direct ownership by 0.95% to 208,710 unitsForm 4Open-market sale10b5-1 plan
- Jul 1, 2022TRDASEC Form 4 filed by Doshi DipalForm 4Grant or award
- Jun 27, 2022-$48KTRDASEC Form 4: Doshi Dipal sold $48,000 worth of shares (4,000 units at $12.00) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 210,710 unitsForm 4Open-market sale10b5-1 plan
- Mar 1, 2022TRDASEC Form 4: Doshi Dipal was granted 30,250 shares, increasing direct ownership by 16% to 214,710 unitsForm 4Grant or award
- Jan 13, 2022TRDASEC Form 4: Doshi Dipal exercised 10,000 shares at a strike of $1.74, increasing direct ownership by 6% to 184,460 unitsForm 4Exercise or conversion of a derivative
- Oct 28, 2021TRDASEC Form 4 filed by Doshi DipalForm 4Grant or award
Compare Dipal Doshi with
- Dipal Doshi vs Olga Pirogova1 shared
- Dipal Doshi vs Lawrence Y. Lin1 shared
- Dipal Doshi vs Ephraim Starr1 shared
- Dipal Doshi vs William E. Martin III1 shared
- Dipal Doshi vs Erik J. Bello1 shared
- Dipal Doshi vs Martin D Madaus1 shared
Other insiders at the same companies
- Olga PirogovaAZTA
- Lawrence Y. LinAZTA
- Ephraim StarrAZTA
- William E. Martin IIIAZTA
- Erik J. BelloAZTA
- Martin D MadausAZTA
- Mpm Bioventures 2018, L.P.TRDA
- MPM BioVentures 2014, L.P.TRDA
- Nathan J DowdenTRDA
- Kory James WentworthTRDA
- Natarajan SethuramanTRDA
- Kush ParmarTRDA
- 5AM Ventures V, L.P.TRDA
- Peter S KimTRDA
- Gina ChapmanTRDA
- Maha RadhakrishnanTRDA
Questions about Dipal Doshi
- What is Dipal Doshi's role at Entrada Therapeutics, Inc.?
- Dipal Doshi reports to the SEC as CEO and director at Entrada Therapeutics, Inc. (TRDA), according to the latest filing on September 3, 2026. Dipal Doshi has also filed as director at Azenta, Inc. (AZTA).
- How many shares does Dipal Doshi own?
- After the latest filing that states it, Dipal Doshi directly owned 517,290 shares of Entrada Therapeutics, Inc. (TRDA) and 9,703 shares of Azenta, Inc. (AZTA). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Dipal Doshi bought or sold stock recently?
- The most recent open-market sale was on July 15, 2024: sold 1,900 shares of Entrada Therapeutics, Inc. (TRDA) for $33.9K at an average of $17.84.
- How do I get alerts when Dipal Doshi files?
- Follow Dipal Doshi on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Dipal Doshi filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Dipal Doshi (SEC CIK 0001613084). Totals count each trade once, skipping amendments whose original is on file, from Nov 1, 2021 on. View on SEC EDGAR · Get this as JSON